Dr Thomas Rabe is follows in the footsteps of Klaus Kühn, CFO at Bayer, who stepped down the board at the end of last year.
As an independent expert and member of the Audit Committee of the supervisory board of Symrise, Dr Rabe will advise the Symrise Group in all financial matters.
“The supervisory board of Symrise is pleased to welcome our new member, Dr Thomas Rabe, who has outstanding expertise in financial issues,” said Andreas Schmid, chairman of the supervisory board.
